nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Bilateral cerebral infarction in the setting of pituitary apoplexy: a case presentation and literature review
|
Banerjee, Christopher |
|
2014 |
18 |
3 |
p. 352-358 |
artikel |
2 |
Effects of low dose versus high dose human growth hormone on body composition and lipids in adults with GH deficiency: a meta-analysis of placebo-controlled randomized trials
|
Newman, Connie B. |
|
2014 |
18 |
3 |
p. 297-305 |
artikel |
3 |
Erratum to: Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study
|
Sheppard, Michael |
|
2015 |
18 |
3 |
p. 395-396 |
artikel |
4 |
Evaluation of survivin splice variants in pituitary tumors
|
Waligórska-Stachura, Joanna |
|
2014 |
18 |
3 |
p. 410-416 |
artikel |
5 |
Extracapsular en bloc resection in pituitary adenoma surgery
|
Kim, Eui Hyun |
|
2014 |
18 |
3 |
p. 397-404 |
artikel |
6 |
Gamma knife radiosurgery for Cushing’s disease and Nelson’s syndrome
|
Marek, Josef |
|
2014 |
18 |
3 |
p. 376-384 |
artikel |
7 |
Giant prolactinomas: clinical manifestations and outcomes of 16 Arab cases
|
Almalki, Mussa H. |
|
2014 |
18 |
3 |
p. 405-409 |
artikel |
8 |
Importance of cannulated prolactin test in the definition of hyperprolactinaemia
|
Whyte, M. B. |
|
2014 |
18 |
3 |
p. 319-325 |
artikel |
9 |
Incidence of Cushing’s syndrome and Cushing’s disease in commercially-insured patients <65 years old in the United States
|
Broder, Michael S. |
|
2014 |
18 |
3 |
p. 283-289 |
artikel |
10 |
Insulin resistance, metabolic syndrome and chronic low grade inflammation in Sheehan’s syndrome on standard replacement therapy: a case control study
|
Bhat, Manzoor Ahmad |
|
2014 |
18 |
3 |
p. 312-318 |
artikel |
11 |
KISS1 receptor is preferentially expressed in clinically non-functioning pituitary tumors
|
Yaron, Marianna |
|
2014 |
18 |
3 |
p. 306-311 |
artikel |
12 |
Low expression of secreted frizzled-related protein 4 in aggressive pituitary adenoma
|
Wu, Youtu |
|
2014 |
18 |
3 |
p. 335-342 |
artikel |
13 |
Octreotide LAR treatment of acromegaly in “real life”: long-term outcome at a tertiary care center
|
Espinosa-de-los-Monteros, Ana Laura |
|
2014 |
18 |
3 |
p. 290-296 |
artikel |
14 |
Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study
|
Sheppard, Michael |
|
2014 |
18 |
3 |
p. 385-394 |
artikel |
15 |
Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly
|
Roerink, S. H. P. P. |
|
2014 |
18 |
3 |
p. 366-375 |
artikel |
16 |
Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype
|
Lee, Cheng-Chia |
|
2014 |
18 |
3 |
p. 326-334 |
artikel |
17 |
The prevalence and associated factors of colorectal neoplasms in acromegaly: a single center based study
|
Yamamoto, Masaaki |
|
2014 |
18 |
3 |
p. 343-351 |
artikel |
18 |
Update on prognostic factors in acromegaly: Is a risk score possible?
|
Fernandez-Rodriguez, E. |
|
2014 |
18 |
3 |
p. 431-440 |
artikel |
19 |
Up-to 5-year efficacy of pasireotide in a patient with Cushing’s disease and pre-existing diabetes: literature review and clinical practice considerations
|
Trementino, Laura |
|
2014 |
18 |
3 |
p. 359-365 |
artikel |
20 |
We stand upon the shoulders of giants!
|
Molitch, Mark E. |
|
2014 |
18 |
3 |
p. 417-430 |
artikel |